- Home
- BTTC vs RNXT Comparison
BTTC vs RNXT Comparison
Compare BTTC & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$1.85
HOLD
Current Price
$0.85
Company Overview
Basic Information| Metric | BTTC | RNXT |
|---|---|---|
| Founded | 1990 | 2012 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.5M | 36.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BTTC | RNXT |
|---|---|---|
| Price | $1.85 | $0.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.75 |
| AVG Volume (30 Days) | ★ 2.8M | 188.0K |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $2,719,480.00 | $928,000.00 |
| Revenue This Year | N/A | $2,795.35 |
| Revenue Next Year | N/A | $272.69 |
| P/E Ratio | $2.46 | ★ N/A |
| Revenue Growth | ★ 2.04 | N/A |
| 52 Week Low | $1.77 | $0.70 |
| 52 Week High | $39.00 | $1.69 |
Technical Indicators
Market Signals| Indicator | BTTC | RNXT |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 42.02 |
| Support Level | N/A | $0.89 |
| Resistance Level | N/A | $1.00 |
| Average True Range (ATR) | 0.00 | 0.07 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 0.00 | 7.06 |
Price Performance
Historical Comparison BTTC
RNXT
About BTTC Black Titan Corporation Ordinary Shares
Black Titan Corp is engaged in software implementation and training. It provides consulting services and Human Resource and Payroll solutions.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.